Hovedindeksen (OSEBX.OL)

Close: 1 238.12 (+14.87), May 20, 2022
Positive

Low risk

Automatic technical analysis. Medium term, May 20, 2022

Hovedindeksen is within an approximate horizontal trend channel in the medium long term. This indicates that investors are uncertain and waiting for signals of further direction. A break upwards will be a positive signal, while a break downwards will be a negative signal. The index has met the objective at 1282 after a break of the rectangle formation. The price has now fallen, but the formation indicates further rise. The index is between support at points 1220 and resistance at points 1284. A definitive break through of one of these levels predicts the new direction. The volume balance is positive and strengthens the index in the short term. The index is overall assessed as technically positive for the medium long term.

Recommendation one to six months: Positive (Score: 57)

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-0.76%7 233.74+1.22%
5 days42.932.45%8 109.41+4.33%
22 days42.975.84%7 694.18-3.20%
66 days11.4810.34%8 181.97+2.01%

More analyses of Hovedindeksen

chart Hovedindeksen (OSEBX) Candlesticks 22 Days
Candlesticks
chart Hovedindeksen (OSEBX) Short term
Short term: Positive
chart Hovedindeksen (OSEBX) Medium term
Medium term: Positive
chart Hovedindeksen (OSEBX) Long term
Long term: Positive
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+